• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.37% Nasdaq Down0.28%




    News & Info


    Analyst Coverage

    • Analyst Opinion
    • Analyst Estimates


    • Major Holders
    • Insider Transactions
    • Insider Roster


    Divi's Laboratories Limited (DIVISLAB.BO)

    1,959.90 Down 12.95(0.66%) 5:58AM EDT
    Add to Portfolio
    ProfileGet Profile for:
    Divi's Laboratories Limited
    7-1-77/E/1/303, Divi Towers
    Dharam Karan Road
    Hyderabad, 500016
    India - Map
    Phone: 91 40 2378 6300
    Fax: 91 40 2378 6460
    Website: http://www.divislaboratories.com

    Index Membership:N/A
    Industry:Drugs - Generic
    Full Time Employees:N/A

    Business Summary 

    Divi’s Laboratories Limited manufactures and sells active pharmaceutical ingredients (API) and intermediates for generics in India. The company also offers building blocks for peptides and nucleotides; carotenoids, such as apocarotenal, betacarotene, lycopene, astaxanthin, canthaxanthin, etc.; nutraceuticals; protected amino acids comprising BOC, FMOC, and CBZ; and novel ligands, including binol, binap, and others. The company also offers custom synthesis of API and advanced intermediates for discovery compounds to pharma companies. It also exports its products primarily to European and the American countries. The company was formerly known as Divi’s Research Center and changed its name to Divi’s Laboratories Limited in 1994. Divi’s Laboratories Limited was founded in 1990 and is headquartered in Hyderabad, India.

    Key Statistics

    Company Websites 
    Home Page
    Search Yahoo! for:
    More on Divi's Laboratories Limited

    Key Executives 
    Dr. Murali Krishna Prasad Divi M. Pharm, Ph.D., 64
    Chairman, Managing Director and Member of Corp. Social Responsibility Committee
    Mr. L. Kishore Babu B.Com, FICWA, FCMA, 63
    Chief Financial Officer and Member of Stakeholders Relationship Committee
    Mr. Kiran S. Divi B. Pharm., M.Pharm, 39
    Pres of Operations, Director of Operations, Exec. Director and Member of Allotment Committee
    Mr. M. Ramesh Babu B.Sc., 49
    Chief Technologist
    Mr. P. Srinivasa Rao M.Pharm, 50
    Chief Technologist
    Amounts are as of Dec 31, 2014 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in INR.